As of April 29, 2025, Werewolf Therapeutics (HOWL) has a market cap of $37.655 million USD. According to our data, Werewolf Therapeutics is ranked No.8269 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 29, 2025 | $37.65 M |
-42.91%
|
Dec 31, 2024 | $65.95 M |
-61.66%
|
Dec 29, 2023 | $0.17 B |
88.29%
|
Dec 30, 2022 | $91.35 M |
-82.79%
|
Dec 31, 2021 | $0.53 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Fate Therapeutics
FATE
|
$0.13 B |
-0.000 M
|
![]() USA
|
![]() Iovance Biotherapeutics
IOVA
|
$1.17 B |
0.000 M
|
![]() USA
|
![]() Adaptimmune Therapeutics
ADAP
|
$69.44 M |
0.000 M
|
![]() UK
|
![]() Atara Biotherapeutics
ATRA
|
$44.00 M |
0.000 M
|
![]() USA
|
![]() Allogene Therapeutics
ALLO
|
$0.33 B |
-0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.23 B |
-0.000 M
|
![]() Switzerland
|
![]() Editas Medicine
EDIT
|
$0.13 B |
0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.85 B |
-0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$40.34 M |
0.000 M
|
![]() USA
|
![]() Beam Therapeutics
BEAM
|
$1.98 B |
-0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.16 B |
0.000 M
|
![]() USA
|
![]() Precision BioSciences
DTIL
|
$55.18 M |
0.000 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$132.39 B |
-0.001 M
|
![]() USA
|
Market Cap | = | HOWL Stock Price | * | HOWL Shares Outstanding |
= | $0.84 | * | 44.83 M | |
= | $37.65 M |